source clustersSource Clusters is the single source of information on regional development in the life sciences sector worldwide.

With content providing broad overviews as well as in-depth coverage of business development trends, company activities, life science cluster collaborations, multi-partner scientific projects and its extensive news coverage, Source Clusters presents the latest management, research, technology and regional development information serving the needs of executives in the internationally growing life sciences sector.

Source Clusters is the essential resource for companies, incubators, science parks, clusters and regional development agencies looking to find a new location or attract new business and exploit new opportunities across the life sciences sector.

Moderna exercises exclusive licence option for Avacta Affimer biotherapeutics development

Avacta logo 11.2.19Moderna logo 4.3.19Moderna, Inc has exercised its option to enter into an exclusive licensing agreement with Avacta Group plc, the developer of Affimer biotherapeutics and reagents, in respect of certain Affimers against a potential therapeutic target that has been part of a research collaboration, licensing and product commercialisation agreement established between the two companies in 2015. Under the terms of the agreement, Avacta may receive undisclosed payments upon future clinical development milestones and royalties in connection with future product sales for Affimer biotherapeutics developed in collaboration with Moderna.

For further information about Avacta Group visit and for further information about Moderna, Inc visit

Last modified onMonday, 04 March 2019 10:08

Latest from Tom Mulligan